Mtumiaji:Mr. Ibrahem/Olanzapine/samidorphan
| Combination of | |
|---|---|
| Olanzapine | Atypical antipsychotic |
| Samidorphan | Opioid antagonist |
| Data ya kikliniki | |
| Majina ya kibiashara | Lybalvi |
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| MedlinePlus | a621051 |
| Taarifa za leseni | US Daily Med:link |
| Kategoria ya ujauzito | ? |
| Hali ya kisheria | ℞-only (US) |
| Njia mbalimbali za matumizi | By mouth |
| Vitambulisho | |
| Nambari ya ATC | ? |
Olanzapine/samidorphan ( OLZ/SAM ), inayouzwa chini ya jina la chapa Lybalvi, ni dawa mseto inayotumika kutibu skizofrenia na ugonjwa wa bipolar I. [1] Inachukuliwa kwa mdomo. [1] Ina olanzapine, antipsychotic isiyo ya kawaida, na samidorphan, mpinzani wa opioid . [1]
Madhara ya kawaida ni pamoja na kuongezeka kwa uzito, usingizi, kinywa kavu, maumivu ya kichwa, kutetemeka, na kuvimbiwa . [1] Madhara mengine yanaweza kujumuisha ongezeko la hatari ya kifo kwa watu walio na shida ya akili, kujiondoa kwa opioid, ugonjwa mbaya wa neuroleptic, kisukari, dyskinesia ya kuchelewa, shinikizo la chini la damu na kusimama, na seli nyeupe za damu . [1] Haipaswi kutumiwa kwa watu wanaotumia opioids . [1] Jinsi olanzapine inavyofanya kazi haijulikani. [1] Samidorphan yupo kujaribu kupunguza uzito kutoka kwa olanzapine. [2] [3]
Mchanganyiko huo uliidhinishwa kwa matumizi ya matibabu nchini Marekani mwaka wa 2021. [1] Haipatikani nchini Uingereza au Ulaya kufikia 2022. [4] Nchini Marekani inagharimu takriban USD 1,500 kwa mwezi kufikia 2022. [5]
Marejeo
[hariri | hariri chanzo]- 1 2 3 4 5 6 7 8 "DailyMed - LYBALVI- olanzapine and samidorphan l-malate tablet, film coated". dailymed.nlm.nih.gov. Ilihifadhiwa kwenye nyaraka kutoka chanzo mnamo 29 Oktoba 2022. Iliwekwa mnamo 29 Oktoba 2022.
{{cite web}}: CS1 maint: date auto-translated (link) - ↑ Citrome L, Graham C, Simmons A, Jiang Y, Todtenkopf MS, Silverman B, DiPetrillo L, Cummings H, Sun L, McDonnell D (2021). "An Evidence-Based Review of OLZ/SAM for Treatment of Adults with Schizophrenia or Bipolar I Disorder". Neuropsychiatr Dis Treat. 17: 2885–2904. doi:10.2147/NDT.S313840. PMC 8437420. PMID 34526769.
{{cite journal}}: CS1 maint: unflagged free DOI (link) - ↑ Paik J (Agosti 2021). "Olanzapine/Samidorphan: First Approval". Drugs. 81 (12): 1431–1436. doi:10.1007/s40265-021-01568-0. PMID 34304374.
{{cite journal}}: CS1 maint: date auto-translated (link) - ↑ "Olanzapine + samidorphan". SPS - Specialist Pharmacy Service. 18 Januari 2017. Ilihifadhiwa kwenye nyaraka kutoka chanzo mnamo 29 Novemba 2021. Iliwekwa mnamo 29 Oktoba 2022.
{{cite web}}: CS1 maint: date auto-translated (link) - ↑ "Lybalvi Prices, Coupons, Copay & Patient Assistance". Drugs.com (kwa Kiingereza). Iliwekwa mnamo 29 Oktoba 2022.
{{cite web}}: CS1 maint: date auto-translated (link)
[[Category:Madawa]]